Hyderabad, Telangana, India, April 2026 – Botanic Healthcare has appointed Kamalakar V. Arcot as its Group Chief Executive Officer, in a move aimed at strengthening its global expansion strategy in the nutraceutical and bioactives segment.
A seasoned executive with over two decades of experience in the global pharmaceutical and life sciences industries, Mr. Arcot brings deep expertise in scaling businesses across regulated and emerging markets. In his new role, he will lead Botanic Healthcare’s strategic vision, drive international expansion, and strengthen operational excellence across geographies.
Mr. Arcot has an extensive track record of managing complex P&L responsibilities across North America, Latin America, Europe, Asia Pacific, and the Middle East. His experience spans the entire pharmaceutical value chain from strategic portfolio development and intellectual property management to supply chain optimization and large-scale commercial execution.
Speaking on his appointment, Kamalakar V. Arcot, Group CEO, Botanic Healthcare, said, “Stepping into this role at Botanic Healthcare feels both humbling and exciting. The nutraceutical space is evolving rapidly, and my focus is to position Botanic as a ‘global-first’ organization with a strong international footprint.”
He added, “I look forward to working closely with our leadership team and global workforce to deliver solutions that are backed by science, powered by technology, and designed to create meaningful impact.”
Gaurav Soni, Founder & Managing Director, Botanic Healthcare, commented, “The nutraceutical and bioactives sector is at an inflection point, with increasing convergence of science, regulation and global demand. Strengthening leadership becomes critical in navigating this complexity and scaling across markets. Kamalakar’s experience across pharmaceutical, nutraceutical and bioactives operations, along with his exposure to global markets, aligns with the direction we are building towards as an organisation.”
Madhu Krishnamani, Founder & Managing Director, added, “Welcoming Kamalakar as our new Group CEO truly marks a pivotal moment for Botanic Healthcare and resonates strongly with our future vision. Leaders like Kamalakar, with their impressive track record of leading organisations through periods of growth and transformation, bring a wealth of expertise, that will further strengthen our leadership team and expand our global reach. Kamalakar’s dynamic energy and innovative perspectives are certain to inspire and motivate us all, setting the stage for fresh opportunities and bold new directions. As we enter this exciting new chapter together, I am confident that, with Kamalakar at the helm, we will achieve significant milestones and build on our momentum for continued success.”
The appointment marks a step in strengthening Botanic Healthcare’s leadership structure as it scales operations globally.
About Botanic Healthcare
Our expertise lies in the identification, development and manufacture of nutra ingredients through innovation. Challenging conventional wisdom through pioneering R&D and a customer-centric approach, our passionate team of inventors and nutritionists are transforming the way health is achieved.
We focus on innovating of new ingredients to meet healthcare and nutrition challenges by using eco-friendly technologies in our manufacturing processes. At Botanic Healthcare, we are distinguish by our through our relentless dedication to excellence in the manufacture of high-quality, bio-available ingredients, for use across health, food, phama, and cosmetic industries worldwide.
Read Also : When HR “Produces Nothing”: A Response to Jennifer Sey’s Anti-HR Vision
The Fine Balance: Navigating Work, Life, and Mental Wellbeing
Mind the Leadership Gap – From Learning to Real-World Impact
How the Adecco Group is empowering its employees for the future of work
